Investment

 

posts

Investment
Science
Programs
Social
Unlocking the Potential of Antibody-Drug Conjugates in Cancer Therapy
Science
Jul 8, 2024

Unlocking the Potential of Antibody-Drug Conjugates in Cancer Therapy

FluoSphera and Revvity Collaborate to Develop a Multiplexed Selectivity Assay for In Vitro Drug Discovery
Science
Jun 11, 2024

FluoSphera and Revvity Collaborate to Develop a Multiplexed Selectivity Assay for In Vitro Drug Discovery

FluoSphera secures $1 million pre-seed investment
Investment
Mar 1, 2023

FluoSphera secures $1 million pre-seed investment

FluoSphera S.A. is Grant Award Recipient of CHF 1.1 million from Innosuisse
Science
Jan 1, 2024

FluoSphera S.A. is Grant Award Recipient of CHF 1.1 million from Innosuisse

ENMEDIA Talks With FluoSphera
Science
May 26, 2024

ENMEDIA Talks With FluoSphera

LSCV Interview
Investment
Jul 26, 2022

LSCV Interview